POST ACUTE MEDICAL AT NANTICOKE — History
CCN 392025 | 3-year financial timeline | COVID resilience: 17/100
🛡️ Public data only — no PHI permitted on this instance.
$12M
Latest Revenue (FY2022)
-12.4%
Revenue CAGR (3yr)
0.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $16M | $14M | $12M | -14.8% | -12.4% |
| Operating Expenses | $14M | $13M | $12M | -9.7% | -6.1% |
| Operating Margin | 13.5% | 6.2% | 0.6% | -89.9% | -78.5% |
| Net Income | $2M | $1M | $0M | -91.4% | -81.2% |
| Licensed Beds | 36 | 36 | 36 | +0.0% | +0.0% |
| Total Patient Days | 8,763 | 7,586 | 6,356 | -16.2% | -14.8% |
| Medicare Day % | 55% | 57% | 60% | +5.2% | +4.4% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 17/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -23.3% ($16M → $12M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-12.4%
This Hospital
+7.6%
State Avg
Latest Margin
0.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $10M | -5.8% |
| FY2024 (proj) | $8M | -12.3% |
| FY2025 (proj) | $7M | -18.7% |